Antimicrobial resistance (AMR) has become a pressing global public health concern, posing a significant threat to the effectiveness of antibiotics in combating infectious diseases. In recent years, the rise of AMR microorganisms has particularly affected low-middle-income countries (LMICs) in Southeast Asia, where the misuse of antibiotics in human and animal health, as well as environmental factors, have exacerbated the problem. Furthermore, the implementation of effective policies to address AMR has encountered various challenges in these regions.
A key issue faced by LMICs is the lack of strong real-time information tools that would enable healthcare providers to make informed decisions regarding antibiotic prescriptions based on current AMR trends and patterns. To ensure that clinicians are prescribing antibiotics in line with the WHO AWaRe (Access, Watch, Reserve) classification, it is crucial to have access to up-to-date data. This data should include information from the hospital and national susceptibility tests, as well as antibiograms. To address this pressing issue and enhance the management of AMR in common infectious diseases, the development of a mobile health (mHealth) application is underway.
The AMR mHealth application offers a range of features and functionalities designed to enhance the management of AMR in common infectious diseases. By leveraging real-time data collection and analysis, clinicians can access crucial information on the prevalence of infectious diseases, the burden they impose on the population, and the most appropriate antibiotic treatments based on their susceptibility to AMR. The integration of the national AMR surveillance data, including antibiotic susceptibility testing (AST) results, further strengthens the application’s effectiveness in guiding treatment decisions.